← ANALYSTS · TIPRANKS
Thomas Smith · Leerink Partners
Hits
57%
275 of 486 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+51.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
21
Buy / hold / sell: 21 / 0 / 0
Upside of the analyst’s targets
+229.2%
Average over 17 current targets, to the last price
The market’s answer to the ratings
+3.3%
Day-0 move against SPY in the rating’s direction, average over 11 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 9on TipRanks Oct 12 05:25 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,115 | +36.1% | +0.2%next day −1.5% · 5 days +1.3% | ↗ |
| Oct 1on TipRanks 13:55 | MLTXMoonLake Immunotherapeutics · $873M | Reiterated | Buy | $30.00 | +214.1% | −2.1%next day −1.3% · 5 days −9.1% | ↗ |
| Oct 1on TipRanks 11:45 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Buy | — | — | −5.3%next day −3.2% · 5 days −6.1% | ↗ |
| Sep 29on TipRanks Sep 30 04:50 | IVAInventiva · $877M | Reiterated | Buy | $12.00 | +308.2% | −6.6%next day +12.4% · 5 days +3.2% | ↗ |
| Sep 23on TipRanks 09:40 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $70.00 → $88.00+25.7% | +219.7% | −6.4%next day +1.2% · 5 days +4.8% | ↗ |
| Sep 10on TipRanks 07:50 | IRONIWMDisc Medicine · $2.2B | Reiterated | Buy | $100 | +75.9% | −2.5%next day −6.4% · 5 days −7.3% | ↗ |
| Sep 10on TipRanks Sep 9 08:35 | SYREIWMSpyre Therapeutics · $7.3B | Assigned | Buy | $124 → $128+3.2% | +60.2% | −3.8%next day +2.6% · 5 days +6.0% | ↗ |
| Sep 10on TipRanks Sep 9 08:35 | EVMNIWMEvommune, Inc. · $215M | Assigned | Buy | $28.00 → $22.00−21.4% | +325.5% | −16.7%next day −2.0% · 5 days −12.5% | ↗ |
| Aug 4on TipRanks 06:06 | KROSIWMKeros Therapeutics · $219M | Reiterated | Buy | $30.00 → $23.00−23.3% | +115.8% | −0.4%next day −2.3% · 5 days +3.9% | ↗ |
| Jul 28on TipRanks 10:21 | ALTIWMAltimmune · $459M | Reiterated | Buy | $10.00 | +354.5% | +0.8%next day −0.8% · 5 days −1.4% | ↗ |
| Jul 24on TipRanks 07:10 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $955 → $1,065+11.5% | +30.0% | −0.8%next day −3.2% · 5 days −8.1% | ↗ |
| Jul 6on TipRanks 11:15 | AVTXIWMAvalo Therapeutics · $644M | Initiated | Buy | $38.00 | +237.2% | +5.1%next day −3.1% · 5 days −5.0% | ↗ |
| Jun 12on TipRanks Jun 15 07:25 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | — | — | +4.3%next day −1.3% · 5 days +5.9% | ↗ |
| Jun 2on TipRanks 06:31 | XFORIWMX4 Pharmaceuticals · $262M | Initiated | Buy | $12.00 | +363.3% | −1.8%next day −1.0% · 5 days −1.7% | ↗ |
| May 27on TipRanks 10:15 | RNACIWMCartesian Therapeutics · $199M | Reiterated | Buy | — | — | +7.5%next day +3.5% · 5 days −10.1% | ↗ |
| May 15on TipRanks 11:20 | ALMSIWMAlumis Inc. · $842M | Reiterated | Buy | $32.00 | +422.9% | −5.9%next day −7.5% · 5 days −4.6% | ↗ |
| Apr 6on TipRanks 13:25 | VRDNIWMViridian Therapeutics · $2.2B | Reiterated | Buy | $50.00 | +162.7% | −26.7%next day +0.4% · 5 days +2.4% | ↗ |
| Apr 2on TipRanks 11:35 | IMVTIWMImmunovant · $5.8B | Reiterated | Buy | $52.00 → $50.00−3.8% | +87.1% | −2.5%next day +1.1% · 5 days −3.6% | ↗ |
| Mar 3on TipRanks Mar 5 05:00 | AGMBAgomAb Therapeutics NV ADR · $434M | Initiated | Buy | $36.00 | +334.8% | −1.0%next day −8.4% · 5 days −13.1% | ↗ |
| Dec 15on TipRanks 15:15 | KYTXIWMKyverna Therapeutics, Inc. · $369M | Reiterated | Buy | $25.00 → $32.00+28.0% | +464.4% | +23.4%next day −5.1% · 5 days −25.8% | ↗ |
| Oct 21on TipRanks Oct 22 06:15 | SABSIWMSAB Biotherapeutics · $236M | Reiterated | Buy | — | — | 0.0%next day +0.5% · 5 days −1.7% | ↗ |
| Oct 15on TipRanks Oct 16 03:55 | ACRSIWMAclaris Therapeutics · $514M | Reiterated | Buy | $7.00 | +113.4% | +6.2%next day +6.9% · 5 days +16.7% | ↗ |
| Oct 1on TipRanks 06:40 | MLTXMoonLake Immunotherapeutics · $873M | Reiterated | Buy | $73.00 → $14.00−80.8% | +46.6% | −1.9%next day +5.6% · 5 days +28.2% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗